Tuberculosis: Ending the Epidemic | Keystone Symposia

Web Desc
MEETING CHANGE TO VIRTUAL: Tuberculosis: Science Aimed at Ending the Epidemic Scientific Organizers: Anne G. Kasmar, Bruno B. Andrade, Rodrigo Corrêa-Oliveira and David Alland Date: December 01 - 05, 2020 Location: Virtual at your computer Part of the Keystone Symposia Global Health Series, supported by the Bill & Melinda Gates Foundation For important information on the coronavirus, please click here Summary of Meeting: For more information on the virtual eSymposia format Click here The global tuberculous (TB) community has decided that now is the time to eradicate this disease and have developed “The End TB Strategy”. This is an initiative that 194 countries have endorsed with the ultimate goal of ending the global endemic. The World Health Organization (WHO) and the STOP TB partnership have crafted the STOP TB Plan, and the Treatment Action Group has mapped the resources required to achieve these audacious goals. At the 2018 United Nations High Level Meeting on TB, the heads of the state made a pledge to succeed in these endeavors. Therefore, the aim of this symposium is to mobilize the rigor, creativity and forward-momentum of scientists worldwide to discover and develop new tools that will end the epidemic. A few unique features of this conference include sessions that will explore advances across the ecosystem from early discovery through translation and real-world application, address scientific bottlenecks to overcome in the search for new tools to prevent, diagnose and definitively cure TB. Finally, the conference will include sessions dedicated to lessons learned from leprosy and from clinical successes in microbiome science and immunotherapy. By bringing together a program such as this, there will be numerous opportunities for scientists to network and build collaborations that will catalyze scientific advances that address the global scourge of TB. Keystone Symposia thanks our Sponsor(s) for generously supporting this meeting: We appreciate the organizations that provide Keystone Symposia with additional support, such as marketing and advertising: Click here to view more of these organizations Special thanks to the following for their support of Keystone Symposia initiatives to increase participation at this meeting by scientists from underrepresented backgrounds: Click here to view more of these organizations

MEETING CHANGE TO VIRTUAL: Tuberculosis: Science Aimed at Ending the Epidemic

Scientific Organizers: Anne G. Kasmar, Bruno B. Andrade, Rodrigo Corrêa-Oliveira and David Alland

Date: December 01 - 05, 2020
Location: Virtual at your computer

Part of the Keystone Symposia Global Health Series, supported by the Bill & Melinda Gates Foundation

For important information on the coronavirus, please click here

Summary of Meeting:

For more information on the virtual eSymposia format Click here

The global tuberculous (TB) community has decided that now is the time to eradicate this disease and have developed “The End TB Strategy”. This is an initiative that 194 countries have endorsed with the ultimate goal of ending the global endemic. The World Health Organization (WHO) and the STOP TB partnership have crafted the STOP TB Plan, and the Treatment Action Group has mapped the resources required to achieve these audacious goals. At the 2018 United Nations High Level Meeting on TB, the heads of the state made a pledge to succeed in these endeavors. Therefore, the aim of this symposium is to mobilize the rigor, creativity and forward-momentum of scientists worldwide to discover and develop new tools that will end the epidemic. A few unique features of this conference include sessions that will explore advances across the ecosystem from early discovery through translation and real-world application, address scientific bottlenecks to overcome in the search for new tools to prevent, diagnose and definitively cure TB. Finally, the conference will include sessions dedicated to lessons learned from leprosy and from clinical successes in microbiome science and immunotherapy. By bringing together a program such as this, there will be numerous opportunities for scientists to network and build collaborations that will catalyze scientific advances that address the global scourge of TB.

Keystone Symposia thanks our Sponsor(s) for generously supporting this meeting:

We appreciate the organizations that provide Keystone Symposia with additional support, such as marketing and advertising:

Click here to view more of these organizations

Special thanks to the following for their support of Keystone Symposia initiatives to increase participation at this meeting by scientists from underrepresented backgrounds:

Click here to view more of these organizations

No content found